🇺🇸 FDA
Pipeline program

The placebo product consists of a soft capsule similar to the ones containing the active substance, VESSEL® 250 ULS capsule molli

Phase 3 small_molecule active

Quick answer

The placebo product consists of a soft capsule similar to the ones containing the active substance, VESSEL® 250 ULS capsule molli for Prevention of recurrence after a first episode of Venous Thromboembolism (VTE) is a Phase 3 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
Prevention of recurrence after a first episode of Venous Thromboembolism (VTE)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials